Irritable bowel syndrome frequency and related factors in hemodialysis patients

Basit Öğe Kaydı
dc.contributor.authorOzkul, Durmus
dc.contributor.authorGuney, Ibrahim
dc.contributor.authorSackan, Fatih
dc.contributor.authorYavuz, Yasemin Coskun
dc.contributor.authorYilmaz, Nedim
dc.contributor.authorTonbul, Halil Z.
dc.date.accessioned2024-02-23T14:24:15Z
dc.date.available2024-02-23T14:24:15Z
dc.date.issued2020
dc.departmentNEÜen_US
dc.description.abstractIntroduction Irritable bowel syndrome (IBS) is a functional bowel disease that is common in society, does not threaten life, impairs quality of life, and causes serious economic losses. Gastrointestinal system complaints and especially IBS are common in patients with chronic kidney disease. It has also been shown that psychiatric diseases are more common in patients with IBS. In this study, we aimed to determine the frequency of IBS in hemodialysis patients and to investigate the factors associated with IBS. Methods In this cross-sectional study, the questionnaire prepared to evaluate depression, anxiety, and abdominal pain was administered face-to-face to 686 patients by the same researcher in seven dialysis centers; 404 patients without exclusion criteria were included in the study. The diagnosis of IBS was made according to Rome IV criteria. A multivariate logistic regression model was used to identify factors that are significantly related to IBS. Findings In 69 (17.1%) of the patients included in the study, symptoms were consistent with IBS. Binominal logistic regression analysis was performed to evaluate the effect of age, dialysis duration, diabetes, proton pump inhibitor, non-steroidal anti-inflammatory drugs, calcium acetate use, Hamilton depression and anxiety scores associated with IBS in the presence of IBS of the participants. The logistic regression model was statistically significant, chi(2) (3) = 69.748, P < 0.001. Independent risk factors for IBS in hemodialysis patients were determined as anxiety, long-term dialysis treatment, and using calcium acetate as a phosphorus binder. Discussion In hemodialysis patients, IBS occurs approximately twice as often as in a healthy population. Independent risk factors for IBS in hemodialysis patients are anxiety, long-term dialysis treatment, and using calcium acetate as a phosphorus binder.en_US
dc.identifier.doi10.1111/hdi.12846
dc.identifier.endpage366en_US
dc.identifier.issn1492-7535
dc.identifier.issn1542-4758
dc.identifier.issue3en_US
dc.identifier.pmid32452111en_US
dc.identifier.scopus2-s2.0-85085572265en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage359en_US
dc.identifier.urihttps://doi.org/10.1111/hdi.12846
dc.identifier.urihttps://hdl.handle.net/20.500.12452/13855
dc.identifier.volume24en_US
dc.identifier.wosWOS:000535173000001en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofHemodialysis Internationalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectHemodialysisen_US
dc.subjectIrritable Bowel Syndromeen_US
dc.subjectAnxietyen_US
dc.subjectDepressionen_US
dc.subjectCalcium Acetateen_US
dc.subjectLanthanumen_US
dc.titleIrritable bowel syndrome frequency and related factors in hemodialysis patientsen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu